CONTROL BIONICS LIMITED — Capital/Financing Update 2022

Jul 24, 2022

==> picture [177 x 63] intentionally omitted <==

25 July 2022

Notice Pursuant to Section 708A(5)(e) of the Corporations Act

Control Bionics Limited ACN 115 465 462 (the Company ) gives notice under section 708A(5)(e) of the Corporations Act as follows:

• (a) On 25 July 2022, the Company issued 3,567,860 fully paid ordinary shares in the Company.

• (b) The shares were issued without disclosure under Part 6D.2 of the Corporations Act.

• (c)

• As at the date of this notice the Company has complied with:

• (i) the provisions of Chapter 2M of the Corporations Act as they apply to the Company; and

• (ii) Section 674 of the Corporations Act.

• (d) As at the date of this notice there is no excluded information required to be disclosed under section 708A(6)(e) of the Corporations Act.

Brett Crowley Company Secretary

Control Bionics Limited Registered Office: Level 5, Suite 5.01, 697 Burke Road, Camberwell, Vic., 3124 T: +61 3 9897 3576 W: www.controlbionics.com

ABN: 45 115 465 462